Evidence map›Paper›PMID 39816564›Full record

ArticleTranslational cancer research2024

Neurofibromatosis with diffuse intestinal ganglioneuromatosis: a case report.

Yangpeng Ni, Weijian Chen, Xiaowei Wu, Shuzhi Huang, Ying Fang

Abstract readCase Reports
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yangpeng NiDepartment of Pathology, Jieyang People's Hospital, Jieyang, China.
Weijian ChenDepartment of Pathology, Jieyang People's Hospital, Jieyang, China.
Xiaowei WuDepartment of Pathology, Jieyang People's Hospital, Jieyang, China.
Shuzhi HuangDepartment of Pathology, Jieyang People's Hospital, Jieyang, China.
Ying FangDepartment of Pathology, Jieyang People's Hospital, Jieyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neurofibromatosis type 1 (NF-1), a rare autosomal dominant disorder, arises from Case Description: This paper reports a case of a 23-year-old male patient with NF1 who underwent a right hemicolectomy due to a cecal mass. Pathological findings were consistent with diffuse intestinal ganglioneuromatosis. Eight months after the surgery, the patient underwent an amputation due to the progressive enlargement of a tumor in his right lower limb, which had been present for 20 years. Pathological results confirmed NF1. Due to the high likelihood of tumor recurrence if only the mass in the right lower limb were to be resected, a surgery involving the amputation of the right lower limb along with the tumor removal was ultimately performed, followed by the installation of a prosthesis postoperatively. To date, the tumor has not recurred. However, due to psychological or skeletal developmental issues, the patient has not regained the ability to walk. Conclusions: This case represents a rare occurrence of neurofibromatosis accompanied by diffuse intestinal ganglioneuromatosis. The discovery and reporting of this rare case enhance the clinical understanding of neurofibromatosis (particularly in terms of uncommon complications) and enrich the clinical spectrum of neurofibromatosis and its complications, offering new insights and approaches for future treatment of similar cases.

Indexed as

case reportganglioneuromatosisintestineNeurofibromatosis

Identifiers

PMID39816564
PMCPMC11729748

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.